Literature DB >> 15043216

Rodent models for HIV-1 infection and disease.

Marc van Maanen1, Richard E Sutton.   

Abstract

The development of a predictive, small animal model for human immunodeficiency virus type 1 (HIV-1) disease would greatly facilitate the analysis of many aspects of viral infection, pathogenesis and treatment. While numerous small animal models exist which emulate various aspects of HIV-1 infection and/or disease in humans, none of these models support robust HIV-1 replication within the context of an intact immune system. Despite this major limitation, these models have helped to elucidate different aspects of HIV-1 pathogenesis in humans. Moreover, recent advances regarding the underlying nature of the blocks to viral replication in non-human cells have raised the possibility that rodents may be engineered to support HIV-1 infection. This review will focus on recent attempts to develop a rodent model for HIV-1 disease, and will also describe currently available systems for studying HIV-1.

Entities:  

Mesh:

Year:  2003        PMID: 15043216     DOI: 10.2174/1570162033352075

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  25 in total

Review 1.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

2.  HIV-1 gp120-induced axonal injury detected by accumulation of β-amyloid precursor protein in adult rat corpus callosum.

Authors:  Jingdong Zhang; Jianuo Liu; Bryan Katafiasz; Howard Fox; Huangui Xiong
Journal:  J Neuroimmune Pharmacol       Date:  2011-02-02       Impact factor: 4.147

3.  HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.

Authors:  Christine Goffinet; Ina Allespach; Oliver T Keppler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-05       Impact factor: 11.205

4.  Skeletal and cardiac myopathy in HIV-1 transgenic rats.

Authors:  Anne M Pruznak; Ly Hong-Brown; Rachel Lantry; Pengxiang She; Robert A Frost; Thomas C Vary; Charles H Lang
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-19       Impact factor: 4.310

5.  Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.

Authors:  Vanessa Rivera-Amill; Richard J Noel; Suheydi Orsini; Griselle Tirado; José M García; Shilpa Buch; Anil Kumar
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

6.  HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.

Authors:  Edward L Evans; Jordan T Becker; Stephanie L Fricke; Kishan Patel; Nathan M Sherer
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

Authors:  Santhi Gorantla; Hannah Sneller; Lisa Walters; John G Sharp; Samuel J Pirruccello; John T West; Charles Wood; Stephen Dewhurst; Howard E Gendelman; Larisa Poluektova
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

8.  Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells.

Authors:  Hila Elinav; Yuanfei Wu; Ayse Coskun; Katarzyna Hryckiewicz; Iris Kemler; Yani Hu; Hilary Rogers; Bing Hao; Choukri Ben Mamoun; Eric Poeschla; Richard Sutton
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

9.  Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.

Authors:  Baoshan Zhang; Ronald C Montelaro
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

10.  Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.

Authors:  Naomi Tsurutani; Jiro Yasuda; Naoki Yamamoto; Byung-Il Choi; Motohiko Kadoki; Yoichiro Iwakura
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.